ReviewPlant biotechnology journal2026
Developing downstream processes for the purification of recombinant proteins and small molecules from Nicotiana benthamiana biomass.
Review in Plant biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Rickettsial Diseases and Vaccines: Is There an Opportunity for Plant-Made Vaccine Technology?Biotechnology and bioengineering · 2026Review
- Performance comparison of downstream unit operations and process chains for the purification of amino acids for food, feed and pharma applications.Biotechnology reports (Amsterdam, Netherlands) · 2026Review
- Polyphenol oxidase depletion in Nicotiana benthamiana enhances recombinant protein purification and preserves native protein integrity.The New phytologist · 2026Article
- Beyond Starch: Towards a Scalable Potato Platform for Molecular Farming.Plant biotechnology journal · 2026Review
- Vector minimization and infiltration optimization for enhanced protein expression in Nicotiana benthamiana.Plant cell reports · 2026Article
- Plant chloroplasts enable high-yield and cost-effective production of the engineered bacterial enzyme CueO-MacHis as a technical protein via transient expression inFrontiers in plant science · 2026Article
- Engineering Conditional Transgene Expression in Nicotiana benthamiana.Plant biotechnology journal · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nicotiana benthamiana (Australian tobacco) has become a major host for plant-based recombinant protein production, especially using transient expression. Once a candidate protein has been designed and produced in a suitable variety (e.g. facilitated humanized glycosylation) under reproducible conditions (e.g. in a vertical farm), the product must be extracted from the biomass and purified to meet the application requirements. For example, >95% purity is often expected for biopharmaceuticals. Here, we review options for and challenges of recombinant protein isolation from N. benthamiana biomass taking inspiration from related host systems when appropriate. Specifically, we first introduce typical properties of the biomass to be processed and then discuss options to harvest it and extract the product, for example, using homogenizers. This includes conditioning steps like heat treatment and means to ensure product integrity. Next, we highlight the advantages and limitations of different clarification operations given the high particle loads typically present in N. benthamiana extracts. Afterwards, we look at product purification using both membrane and chromatographic unit operations focusing on the specific aspects of plant molecular farming. We briefly discuss the potentials of modelling and artificial intelligence in downstream process development and conclude with a short outlook on future developments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.